Chishala Chabala, Tom G Jacobs, Cinta Moraleda, John M Ndaferankhande, Vivian Mumbiro, Alfeu Passanduca, Natasha Namuziya, Damalie Nalwanga, Victor Musiime, Alvaro Ballesteros, Sara Domínguez-Rodríguez, Moses Chitsamatanga, Uneisse Cassia, Bwendo Nduna, Justina Bramugy, Jahit Sacarlal, Lola Madrid, Kusum J Nathoo, Angela Colbers, David M Burger, Veronica Mulenga, W Chris Buck, Hilda A Mujuru, Lindsey H M Te Brake, Pablo Rojo, Alfredo Tagarro, Rob E Aarnoutse
Optimal antituberculosis therapy is essential for favourable clinical outcomes. Peak plasma concentrations of first-line antituberculosis drugs in infants with living HIV receiving WHO-recommended dosing were low compared to reference values for adults, supporting studies on increased doses of first-line TB drugs in infants.
October 16, 2023: Journal of the Pediatric Infectious Diseases Society